Taysha Gene Therapies Inc Strategic Asset Allocation Index
Taysha Gene Therapies Inc strategic asset allocation index. Taysha Gene Therapies Inc (TSHA) has a Strategic Asset Allocation Index of 2729.8% as of December 2022. Strategic assets (PP&E of $25.91 Million plus long-term investments of $-) total $25.91 Million, measured against net assets of $949.00K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how tangible is Taysha Gene Therapies Inc's equity to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Taysha Gene Therapies Inc (2020–2021)
Strategic asset allocation index of Taysha Gene Therapies Inc from 2020 to 2021. This chart shows how Taysha Gene Therapies Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of December 2022, the index stands at 2729.8%, representing strategic assets of $25.91 Million against net assets of $949.00K USD.
Taysha Gene Therapies Inc Strategic Asset Allocation Index by Year (2020–2021)
Taysha Gene Therapies Inc strategic asset allocation index by year from 2020 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Taysha Gene Therapies Inc from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Taysha Gene Therapies Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 53.1% | $50.61 Million | $50.61 Million | $- | $95.38 Million | ▲ +52.9 pp |
| 2020 | 0.1% | $287.00K | $287.00K | $- | $251.30 Million | — |